Effect of treatment on calcium kinetics in metabolic bone disease.
D000328:Adult; D000368:Aged; D001847:Bone Diseases / Q000628:therapy*; D002118:Calcium / Q000378:metabolism* / Q000627:therapeutic use; D002127:Calcium Isotopes; D002128:Calcium Metabolism Disorders / Q000628:therapy*; D002675:Child, Preschool; D003707:Demeclocycline / Q000627:therapeutic use; D004035:Diet Therapy; D004044:Dietary Proteins; D005260:Female; D005983:Glutens; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D007223:Infant; D007700:Kinetics; D008297:Male; D008696:Methandrostenolone / Q000627:therapeutic use; D008875:Middle Aged; D010024:Osteoporosis / Q000628:therapy*; D012279:Rickets / Q000188:drug therapy*; D013752:Tetracycline / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D002127:Calcium Isotopes; D004044:Dietary Proteins; D006852:Hydrochlorothiazide; D014807:Vitamin D; D003707:Demeclocycline; D005983:Glutens; D008696:Methandrostenolone; D013752:Tetracycline; D002118:Calcium